Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Absci CorpABSI · Entity 4685 | Director | June 04, 2026 | June 09, 2026 |
| BIOGEN INC.BIIB · Entity 1675 | Director | June 09, 2026 | June 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Absci Corp
Report date June 04, 2026 · Filed June 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 242,408 |
Reported balance
After 2026-06-04 transaction · row 1
1 source rowRow 1 · 2026-06-04 · Grant · Acquired 10,100 · Balance 242,408 F1: The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Absci Corporation 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest and be settled in full on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such date. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.34 · Expires 2036-06-03 | Direct | 39,800 |
Reported balance
After 2026-06-04 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-04 · Grant · Acquired 39,800 · Balance 39,800 F2: The shares subject to this option vest and become exercisable in full on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Absci Corporation 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest and be settled in full on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such date.
F2: The shares subject to this option vest and become exercisable in full on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such date.
BIOGEN INC.
Report date June 09, 2026 · Filed June 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,875 |
Ending reported balance
After 2026-06-09 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-06-09 · Exercise / conversion · Acquired 2,370 · Balance 2,370 Row 2 · 2026-06-09 · Grant · Acquired 1,505 · Balance 3,875 F1: The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 9, 2026. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2026-06-17 | Direct | 0 |
Reported balance
After 2026-06-09 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-09 · Exercise / conversion · Disposed 2,370 · Balance 0 F2: The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 17, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 9, 2026.
F2: The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 17, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 09, 2026 Filed Jun 11, 2026 21:21 UTC | BIOGEN INC. BIIB · Entity 1675 | Exercise / conversionRestricted Stock Unit · Derivative | 2,370 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000055 · form4.xml · derivative · entry 3 Pangalos Menelas N · CIK 0002001873 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,370 shares Expires 2026-06-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 17, 2025. Read SEC document |
| June 09, 2026 Filed Jun 11, 2026 21:21 UTC | BIOGEN INC. BIIB · Entity 1675 | GrantCommon Stock | 1,505 | $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000055 · form4.xml · nonDerivative · entry 2 Pangalos Menelas N · CIK 0002001873 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,875 F1 · shares: The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 9, 2026. Read SEC document |
| June 09, 2026 Filed Jun 11, 2026 21:21 UTC | BIOGEN INC. BIIB · Entity 1675 | Exercise / conversionCommon Stock | 2,370 | $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000055 · form4.xml · nonDerivative · entry 1 Pangalos Menelas N · CIK 0002001873 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,370 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 04, 2026 Filed Jun 9, 2026 01:29 UTC | Absci Corp ABSI · Entity 4685 | GrantStock Option (right to buy) · Derivative | 39,800 | $0.00 Strike: $7.34 | $0.00 |
DisclosureSEC source: 0001672688-26-000109 · wk-form4_1780968576.xml · derivative · entry 2 Pangalos Menelas N · CIK 0002001873 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,800 Underlying: Common Stock · 39,800 shares Expires 2036-06-03 F2 · derivative.exercise_date: The shares subject to this option vest and become exercisable in full on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such date. Read SEC document |
| June 04, 2026 Filed Jun 9, 2026 01:29 UTC | Absci Corp ABSI · Entity 4685 | GrantCommon Stock | 10,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001672688-26-000109 · wk-form4_1780968576.xml · nonDerivative · entry 1 Pangalos Menelas N · CIK 0002001873 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 242,408 F1 · shares: The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Absci Corporation 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest and be settled in full on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such date. Read SEC document |
| May 13, 2026 Filed May 13, 2026 20:05 UTC | Absci Corp ABSI · Entity 4685 | PurchaseCommon Stock | 37,453 | $5.36 | $200,748.08 |
DisclosureSEC source: 0001672688-26-000091 · wk-form4_1778702713.xml · nonDerivative · entry 1 Pangalos Menelas N · CIK 0002001873 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 232,308 F1 · shares: Open market purchase of shares in accordance with Issuer's trading policies. F1 · acquired: Open market purchase of shares in accordance with Issuer's trading policies. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 23:56 UTC | Absci Corp ABSI · Entity 4685 | GrantStock Option (right to buy) · Derivative | 22,800 | $0.00 Strike: $2.80 | $0.00 |
DisclosureSEC source: 0001672688-26-000043 · wk-form4_1772755011.xml · derivative · entry 2 Pangalos Menelas N · CIK 0002001873 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,800 Underlying: Common Stock · 22,800 shares Expires 2036-03-01 F2 · shares: The shares subject to this option issued in connection with service as a member of the scientific advisory board shall vest and become exercisable over a one year period beginning January 1, 2026, in substantially equal monthly installments, subject to the Reporting Person's continuous service through each vesting date. F2 · derivative.exercise_date: The shares subject to this option issued in connection with service as a member of the scientific advisory board shall vest and become exercisable over a one year period beginning January 1, 2026, in substantially equal monthly installments, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 23:56 UTC | Absci Corp ABSI · Entity 4685 | GrantCommon Stock | 5,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001672688-26-000043 · wk-form4_1772755011.xml · nonDerivative · entry 1 Pangalos Menelas N · CIK 0002001873 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 194,855 F1 · shares: The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Absci Corporation 2021 Stock Option and Incentive Plan in connection with service as a member of the scientific advisory board. The RSUs shall vest and be settled in full over a one year period beginning January 1, 2026, in substantially equal monthly installments, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:13 UTC | Absci Corp ABSI · Entity 4685 | PurchaseCommon Stock | 75,095 | $2.74 | $205,760.30 |
DisclosureSEC source: 0001672688-26-000026 · wk-form4_1772572396.xml · nonDerivative · entry 1 Pangalos Menelas N · CIK 0002001873 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 189,055 F1 · kind: Open market purchase of shares in accordance with Issuer's trading policies. Read SEC document |
| September 22, 2025 Filed Sep 24, 2025 20:03 UTC | Absci Corp ABSI · Entity 4685 | PurchaseCommon Stock | 95,785 | $2.66 | $254,788.10 |
DisclosureSEC source: 0001672688-25-000053 · wk-form4_1758744221.xml · nonDerivative · entry 1 Pangalos Menelas N · CIK 0002001873 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,960 F1 · shares: Open market purchase of shares in accordance with Issuer's trading policies. Read SEC document |
| June 17, 2025 Filed Jun 18, 2025 21:05 UTC | BIOGEN INC. BIIB · Entity 1675 | GrantRestricted Stock Unit · Derivative | 2,370 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-017767 · form4.xml · derivative · entry 1 Pangalos Menelas N · CIK 0002001873 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,370 Underlying: Common Stock · 2,370 shares Expires 2026-06-17 F1 · derivative.exercise_date: The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 17, 2025. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 23:08 UTC | Absci Corp ABSI · Entity 4685 | GrantStock Option (right to buy) · Derivative | 57,400 | $0.00 Strike: $3.01 | $0.00 |
DisclosureSEC source: 0001672688-25-000037 · wk-form4_1749769704.xml · derivative · entry 2 Pangalos Menelas N · CIK 0002001873 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,400 Underlying: Common Stock · 57,400 shares Expires 2035-06-10 F2 · derivative.exercise_date: The shares subject to this option vest and become exercisable in full on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such date. Read SEC document |
| June 11, 2025 Filed Jun 12, 2025 23:08 UTC | Absci Corp ABSI · Entity 4685 | GrantCommon Stock | 14,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001672688-25-000037 · wk-form4_1749769704.xml · nonDerivative · entry 1 Pangalos Menelas N · CIK 0002001873 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,175 F1 · shares: The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Absci Corporation 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest and be settled in full on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such date. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 20:40 UTC | Absci Corp ABSI · Entity 4685 | GrantStock Option (right to buy) · Derivative | 15,114 | $0.00 Strike: $4.96 | $0.00 |
DisclosureSEC source: 0001672688-24-000029 · wk-form4_1718397606.xml · derivative · entry 2 Pangalos Menelas N · CIK 0002001873 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,114 Underlying: Common Stock · 15,114 shares Expires 2034-06-11 F2 · derivative.exercise_date: The shares subject to this option vest and become exercisable in full on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such date. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 20:40 UTC | Absci Corp ABSI · Entity 4685 | GrantCommon Stock | 3,675 | $0.00 | $0.00 |
DisclosureSEC source: 0001672688-24-000029 · wk-form4_1718397606.xml · nonDerivative · entry 1 Pangalos Menelas N · CIK 0002001873 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,675 F1 · shares: The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Absci Corporation 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest and be settled in full on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such date. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:58 UTC | Absci Corp ABSI · Entity 4685 | GrantStock Option (right to buy) · Derivative | 18,900 | $0.00 Strike: $3.69 | $0.00 |
DisclosureSEC source: 0001672688-24-000006 · wk-form4_1704405495.xml · derivative · entry 2 Pangalos Menelas N · CIK 0002001873 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,900 Underlying: Common Stock · 18,900 shares Expires 2034-01-01 F2 · derivative.exercise_date: The shares subject to this option vest and become exercisable in 24 approximately equal monthly installments beginning on January 1, 2024, subject to the Reporting Person's continuous service to the Issuer on each such date. Read SEC document |
| January 02, 2024 Filed Jan 4, 2024 21:58 UTC | Absci Corp ABSI · Entity 4685 | GrantStock Option (right to buy) · Derivative | 106,200 | $0.00 Strike: $3.69 | $0.00 |
DisclosureSEC source: 0001672688-24-000006 · wk-form4_1704405495.xml · derivative · entry 1 Pangalos Menelas N · CIK 0002001873 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,200 Underlying: Common Stock · 106,200 shares Expires 2034-01-01 F1 · derivative.exercise_date: The shares subject to this option vest and become exercisable in 36 approximately equal monthly installments beginning on January 1, 2024, subject to the Reporting Person's continuous service to the Issuer on each such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.